When your business depends on your intellectual property, patent litigation can disrupt product lines or put your business model at risk. In these high-stakes situations, who you trust to protect your most important assets is crucial.
At the intersection of law and science, DLA Piper has a proven track record of driving successful outcomes in complex cases. With a proven reputation for trying and winning cases, we are a go-to firm for our clients’ most important litigation. Our experience defending clients in more US district court cases than any other full-service law firm (Lex Machina 2024) means we offer battle-tested strategies that provide peace of mind.
Leveraging the strength of our powerful global platform, we seamlessly manage complex patent matters across jurisdictions and venues worldwide. We are at home in all the major jurisdictions in the US including the most active patent litigation courts.
“With patent litigations strategically placed in key jurisdictions worldwide, our team is highly adept at managing complex patent matters in multiple venues simultaneously.”
With a deep bench of lawyers with advanced technical and scientific degrees, we leverage technical know-how to develop winning strategies when assets are challenged. We are up-to-speed on the nuances of nearly every type of asset from day one, saving valuable time and resources. We translate technical facts to judges, juries, and expert witnesses – an advantage in trials.
Our leading appellate practice helps clients hold on to their victory and reverse adverse results. We also have extensive experience handling inter partes reviews and post-grant reviews before the United States Patent and Trademark Office, as well as supporting clients in opposition proceedings before the European Patent Office.
Our trial-ready lawyers combine experience, technical proficiency, bench strength, and seamless geographic coverage to develop litigation strategies aimed at protecting your most important assets.
Awards and recognition
Experience
Our experience includes advising or acting for:
Many of the world's top multinational innovator life sciences and medical devices companies on a full range of patent issues, including patent management and patent litigation, and disputes relating to a wide variety of their products including anti-cancer medications, proton pump inhibitors, selective serotonin reuptake inhibitors, calcium channel blockers, selective 5-HT3 receptor antagonists, JAK inhibitors, statins, pain medications, atypical antipsychotics, antihistamines, arthritis medications, anti-fungal medications, smoking cessation medications, vaccines, antibiotics, and insulin
Automotive OEMs and Tier 1 suppliers for over 25 years, litigating patents related to automotive, aeronautical, and safety technologies including the assertion and licensing of SEPs
Clients in litigation and ITC investigations involving SEPs and fair, reasonable and non-discriminatory (FRAND) licensing issues related to a wide range of communications technology standards, for example, power control mechanisms and wireless charging technology
A global technology giant in relation to a high profile, multijurisdictional patent litigation case. Our global team successfully represented the client in a 27-patent case in the Northern District of Texas and three High Court trials in the UK, resulting in a confidential worldwide settlement. This matter involved strategic, cross-border coordination of complex patent litigation across the US, the UK, and other jurisdictions. It also involved complex issues relating to antitrust and anti-competition claims, standard-setting claims, and defenses and issues concerning what constitutes a FRAND licensing commitment in the standard-setting context.
A data protection software client in a patent trial in the US District of Delaware; we won a full defense jury verdict. Our client’s rival asserted that our client and the other defendants infringed two patents relating to fundamental technology for anti-virus software. At trial, our client demonstrated that it invented the same technology years before its rival filed for its patents, and following a three-week trial before Chief Judge Gregory Sleet, the jury unanimously agreed, finding both asserted patents invalid and not infringed. The lawsuit involved global discovery efforts (across the US, the UK, Israel, Czech Republic and France) and several interrelated lawsuits spanning multiple years.
A US-based technology company as lead counsel in an ITC investigation. We helped our client prevail in an important case in which their competitor alleged that our client’s SRAM chips infringed four patents. The Administrative Law Judge’s Initial Determination found no violation of Section 337, finding that none of the four patents were infringed and that the Complainant had failed to establish a domestic industry as to any of the four patents. The Commission subsequently affirmed the finding of no violation on each of these grounds and additionally found the asserted claims of one of the patents invalid.
Advising a global, NYSE-listed medical technology manufacturer of a drug delivery system in patent infringement proceedings in the UK, France and Germany, relating to patents for syringe pump drivers.
